Hassina Baraki,Georg Lutter,Frieder Wolf et al.
Hassina Baraki et al.
Embolic Protection With the Emboliner for Structural Heart Procedures With Extreme Embolic Risk [0.03%]
极高栓塞风险结构性心脏病术式的EmboLiner栓塞保护装置临床研究
Emily Tat,Anton Camaj,Isaac George et al.
Emily Tat et al.
Jet-to-Commissure Index Predicts Procedural Results in Transcatheter Mitral Valve Edge-to-Edge Repair for Functional Mitral Regurgitation [0.03%]
经导管二尖瓣缘对缘修复治疗功能性的二尖瓣反流的术前结果预测指标：夹角到沟间距离指数
Giorgio Fiore,Margherita Fabris,Giacomo Ingallina et al.
Giorgio Fiore et al.
2-Year Outcomes Following Transseptal Mitral Valve Replacement With the HighLife System [0.03%]
经隔膜二尖瓣置换术使用HighLife系统的两年随访结果
Mirjam Keßler,Leonhard-Moritz Schneider,Wen Yeow et al.
Mirjam Keßler et al.
Left Atrial Appendage Occlusion: Are Accumulating Data Enough to Change Clinical Practice? [0.03%]
左心耳封堵：积累的数据足以改变临床实践吗？
Apostolos Tzikas,Athanasios Samaras
Apostolos Tzikas
1-Year Real-World Outcomes With the Amulet Occluder From the EMERGE LAA Postapproval Study [0.03%]
AMULET封堵器一年内真实世界应用结果——来自EMERGE左心耳术后注册研究的数据报告
Dhanunjaya Lakkireddy,Atman P Shah,Himanshu Agarwal et al.
Dhanunjaya Lakkireddy et al.
Background: The Amulet occluder is indicated to reduce the risk for thrombus embolization from the left atrial appendage in patients with nonvalvular atrial fibrillation. ...
Observational Study
JACC. Cardiovascular interventions. 2026 May 11;19(9):1139-1151. DOI:10.1016/j.jcin.2026.02.016 2026
Precision Medicine With Individualized Clinical Surveillance After TAVR [0.03%]
经导管主动脉瓣置换术后的精准医疗及个体化临床监测
Nicolas M Van Mieghem,João L Cavalcante
Nicolas M Van Mieghem
Long-Term Outcomes in Patients With New-Onset Left Bundle Branch Block Following TAVR [0.03%]
经导管主动脉瓣置换术后新发左束支阻滞患者的长期预后
Carla Benavent-García,Marisa Avvedimento,Pedro Cepas-Guillén et al.
Carla Benavent-García et al.
Background: New-onset persistent left bundle branch block (NOP-LBBB) is a frequent conduction disturbance following transcatheter aortic valve replacement (TAVR), yet its long-term prognostic significance remains uncertai...
Observational Study
JACC. Cardiovascular interventions. 2026 May 11;19(9):1124-1134. DOI:10.1016/j.jcin.2026.03.010 2026
Transseptal TMVR With the Cephea Valve: A Step in the Right Direction [0.03%]
经 septalTMVR 与 Cephea瓣膜：正确的方向上的一步
Joseph Kassab,Serge C Harb,Dharam J Kumbhani
Joseph Kassab
30-Day Outcomes of a Single-Stage Transfemoral Mitral Valve Replacement System in Severe Mitral Valve Disease [0.03%]
经股单瓣膜置换系统治疗重度二尖瓣病变的30天结果
Pradeep K Yadav,Torsten P Vahl,Vinod H Thourani et al.
Pradeep K Yadav et al.
Background: Transfemoral (TF) transcatheter mitral valve replacement (TMVR) has emerged as a therapeutic alternative for the treatment of patients with symptomatic mitral valve disease in patients with high surgical risk....